PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2015 | $20,000 | +5.3% | 4,000 | +37.9% | 0.00% | +33.3% |
Q2 2015 | $19,000 | -5.0% | 2,900 | 0.0% | 0.00% | -25.0% |
Q1 2015 | $20,000 | -9.1% | 2,900 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $22,000 | 0.0% | 2,900 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $22,000 | -21.4% | 2,900 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $28,000 | +16.7% | 2,900 | 0.0% | 0.01% | +20.0% |
Q1 2014 | $24,000 | – | 2,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |